Early clinical trial results, presented at addiction medicine conferences in 2024 and 2025, have reported that participants on semaglutide experienced fewer heavy drinking days, lower craving scores on validated assessment tools, and in some cohorts spontaneous reductions in other substance use that wasnt being directly targeted
However, it is consistent with other studies, so it warrants further study to better understand the biological mechanisms. Public health implications The researchers acknowledged study limitations, including the potential for confounding in observational studies and the fact that several cancer types in the analysis had low event rates, leading to wide confidence intervals and limiting statistical power
Ann Internal Med
If you want the complete peptide playbook made by a women and FOR women, Monica created The Modern Womans Peptide Course just for you
I know a lot of people who are sceptical and who are not willing to be guinea pigs, she says
These organizations did not play any role in the conduct, analysis, or interpretation of the studys data
.png)
